Paul Tambyah, MBBS (S'pore), Diplomate, American Board of Internal Medicine and Infectious Diseases

Senior Consultant
National University Hospital, Singapore, Singapore

Disclosure(s): Moderna: Grant/Research Support; Sanofi-Pasteur: Grant/Research Support

Poster(s):

• (P-244) Antibiotic Prescribing Patterns in Ventilator Associated Pneumonia and their Effect on Carbapenem Resistant Organism Colonisation in Asian Hospitals
  Thursday, October 17, 2024

  12:15 PM – 1:30 PM US PT

• (P-1035) Hypo- and hyper-inflammatory phenotypes both predict adverse clinical outcomes in patients with presumed and confirmed Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-1322) Transmission Dynamics of Escherichia coli Sequence Type 131 Amongst Community Dwelling Households: A Prospective Cohort Study
  Friday, October 18, 2024

  12:15 PM – 1:30 PM US PT

• (P-2276) Shifting trends over time in patients admitted with presumed or confirmed Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection from 2006 to 2023 in Singapore
  Saturday, October 19, 2024

  12:15 PM – 1:30 PM US PT